KIMS Increases Stake in Sarvejana Healthcare to 75.53% for ₹148.09 Crore
Krishna Institute of Medical Sciences Limited (KIMS) acquired an additional 6.94% stake in its material subsidiary, Sarvejana Healthcare Private Limited (Sunshine Hospital), for ₹148.09 crore. This increases KIMS's total holding to 75.53%. Sunshine Hospital reported a turnover of ₹597.00 crore for FY25. The acquisition was completed on December 19, 2025.
The acquisition represents a material increase in stake in a subsidiary and involves a significant financial outlay, which could have a medium-term impact on the company's financial performance and strategic direction.
The acquisition of an additional stake in a subsidiary indicates strategic growth and expansion for the company, which is generally viewed positively by investors.
Krishna Institute of Medical Sciences Limited (KIMS) has announced a further investment in its material subsidiary, Sarvejana Healthcare Private Limited (Sunshine Hospital). The company acquired an additional 6.94% equity stake through a secondary purchase, increasing its total holding to 75.53%.
The total paid-up equity share capital of Sunshine Hospital is ₹36,51,60,900, and its turnover for the financial year ended March 31, 2025, was ₹597.00 crore. The cost of acquiring the additional 6.94% equity shares was approximately ₹148.09 crore in cash.
Sunshine Hospital, incorporated on December 3, 2008, is primarily an orthopedic hospital with services in cardiology and transplant, located in Hyderabad, Telangana. Its turnover for FY24 was ₹464.20 crore and for FY23 was ₹419.44 crore. The acquisition does not fall under related party transactions.
This strategic investment was completed on December 19, 2025.
What to do with a filing like this
Krishna Institute of Medical Sciences Limited filed this with the NSE as a statutory disclosure, categorised under acquisition. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Krishna Institute of Medical Sciences Limited. Read the original for the full detail.